Gregory Brooks Bass serves as Executive at Lipocine Inc., where they oversee executive responsibilities. Since joining the company, Gregory Brooks Bass has executed 2 insider transactions totaling $13.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2017 involved exercising options for 9,375 shares valued at $0.
Gregory Brooks Bass currently holds 9,375 shares of Lipocine Inc. (LPCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Brooks Bass has been a net seller of LPCN stock. They have purchased $0 and sold $13.0K worth of shares.
Gregory Brooks Bass's most recent insider trade was on Dec 29, 2017, when they sold 9,375 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.47 |
| Discretionary |